The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Open accessAbstract
Advances in nanotechnology have favored the development of novel colloidal formulations able to modulate the pharmacological and biopharmaceutical properties of drugs. The peculiar physico-chemical and technological properties of nanomaterial-based therapeutics have allowed for several successful applications in the treatment of cancer. The size, shape, charge and patterning of nanoscale therapeutic molecules are parameters that need to be investigated and modulated in order to promote and optimize cell and tissue interaction. In this review, the use of polymeric nanoparticles as drug delivery systems of anticancer compounds, their physico-chemical properties and their ability to be efficiently localized in specific tumor tissues have been described. The nanoencapsulation of antitumor active compounds in polymeric systems is a promising approach to improve the efficacy of various tumor treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Nanoparticles: Properties, applications and toxicities
Khan, I., Saeed, K., & Khan, I. (2019) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2017.05.011 · Cited by 6,244
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 6×
“Recognizing the importance of these physicochemical formulation factors, the European Medical Agency (EMA) and the FDA (Caputo et al., 2019; https:// www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UM588857.pdf) both signal the need for the pre-clinical characterization of nanoparticles.”
BackgroundMethodInfluentialPEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Colorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,783
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering
Gentile, P., Chiono, V., Carmagnola, I., & Hatton, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033640 · Cited by 1,593
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery
Cheng, R., Meng, F., Deng, C., Klok, H.-A., & Zhong, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.084 · Cited by 1,354
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Fleige, E., Quadir, M. A., & Haag, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.020 · Cited by 1,111
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Alcázar-Alay, S. C., & Meireles, M. A. A. (2015) · Food Science and Technology (Campinas) · doi:10.1590/1678-457x.6749 · Cited by 911
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Nanoprecipitation process: From encapsulation to drug delivery
Martínez Rivas, C. J., Tarhini, M., Badri, W., Miladi, K., Greige-Gerges, H., Nazari, Q. A., Galindo Rodríguez, S. A., Román, R. Á., Fessi, H., & Elaissari, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.064 · Cited by 733
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Bertrand, N., Grenier, P., Mahmoudi, M., Lima, E. M., Appel, E. A., Dormont, F., Lim, J.-M., Karnik, R., Langer, R., & Farokhzad, O. C. (2017) · Nature Communications · doi:10.1038/s41467-017-00600-w · Cited by 708
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.11.067 · Cited by 702
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Crucho, C. I. C., & Barros, M. T. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.06.004 · Cited by 696
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687 · cited 1×
“In the first phase, hypoxia induces an increase of the hypoxia-inducible factormediated transcription of pro-angiogenic proteins such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and tumor necrosis factor-α (TNF-α) (Wigerup et al., 2016).”
BackgroundHoang Thi, T. T., Pilkington, E. H., Nguyen, D. H., Lee, J. S., Park, K. D., & Truong, N. P. (2020) · Polymers · doi:10.3390/polym12020298 · Cited by 668
Perrault, S. D., & Chan, W. C. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907069u · Cited by 658
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Recent applications of PLGA based nanostructures in drug delivery
Mir, M., Ahmed, N., & Rehman, A. U. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.038 · Cited by 621
Polymeric micelle for tumor pH and folate-mediated targeting
Lee, E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00239-6 · Cited by 618
Progress in research on paclitaxel and tumor immunotherapy
Zhu, L., & Chen, L. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0164-y · Cited by 616
Harnessing albumin as a carrier for cancer therapies
Hoogenboezem, E. N., & Duvall, C. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.011 · Cited by 610
Nanoparticle decoration with surfactants: Molecular interactions, assembly, and applications
Heinz, H., Pramanik, C., Heinz, O., Ding, Y., Mishra, R. K., Marchon, D., Flatt, R. J., Estrela-Lopis, I., Llop, J., Moya, S., et al. (2017) · Surface Science Reports · doi:10.1016/j.surfrep.2017.02.001 · Cited by 608
Nanocarriers for cancer-targeted drug delivery
Kumari, P., Ghosh, B., & Biswas, S. (2016) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1051049 · Cited by 607
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Formulation of Poloxamers for Drug Delivery
Bodratti, A., & Alexandridis, P. (2018) · Journal of Functional Biomaterials · doi:10.3390/jfb9010011 · Cited by 589
The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine
Cai, R., & Chen, C. (2019) · Advanced Materials · doi:10.1002/adma.201805740 · Cited by 589
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Nanoparticle-based drug delivery systems for cancer therapy
Dang, Y., & Guan, J. (2020) · Smart Materials in Medicine · doi:10.1016/j.smaim.2020.04.001 · Cited by 553
Natural biodegradable polymers based nano-formulations for drug delivery: A review
George, A., Shah, P. A., & Shrivastav, P. S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.011 · Cited by 548
Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
Zhong, Y., Meng, F., Deng, C., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm5003009 · Cited by 541
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
Biopolymer-based nanoparticles and microparticles: Fabrication, characterization, and application
Joye, I. J., & McClements, D. J. (2014) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2014.07.002 · Cited by 527
The applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Ling, D., Park, W., Park, S.-J., Lu, Y., Kim, K. S., Hackett, M. J., Kim, B. H., Yim, H., Jeon, Y. S., Na, K., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4108287 · Cited by 517
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
A Perspective on Polylactic Acid-Based Polymers Use for Nanoparticles Synthesis and Applications
Casalini, T., Rossi, F., Castrovinci, A., & Perale, G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00259 · Cited by 500
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
Chang, S. S., O’Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (1999) · PubMed · Cited by 471
An, F.-F., & Zhang, X.-H. (2017) · Theranostics · doi:10.7150/thno.19365 · Cited by 436
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature
BAZAK, R., HOURI, M., ACHY, S. E., HUSSEIN, W., & REFAAT, T. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.356 · Cited by 435
Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 427
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Albumin nanostructures as advanced drug delivery systems
Karimi, M., Bahrami, S., Ravari, S. B., Zangabad, P. S., Mirshekari, H., Bozorgomid, M., Shahreza, S., Sori, M., & Hamblin, M. R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1193149 · Cited by 422
Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids
VROMAN, L. (1962) · Nature · doi:10.1038/196476a0 · Cited by 403
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment: Miniperspective
Waghray, D., & Zhang, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01457 · Cited by 400
Recent progress in biomedical applications of pluronic (PF127): Pharmaceutical perspectives
Akash, M. S. H., & Rehman, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.032 · Cited by 394
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 379
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030159 · Cited by 368
Self-citationStarch-based biodegradable hydrogels with potential biomedical applications as drug delivery systems
Elvira, C., Mano, J. F., San Román, J., & Reis, R. L. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00322-2 · Cited by 357
The evolving landscape of drug products containing nanomaterials in the United States
D'Mello, S. R., Cruz, C. N., Chen, M.-L., Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.67 · Cited by 345
Lee, B. K., Yun, Y., & Park, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.020 · Cited by 340
Caputo, F., Clogston, J., Calzolai, L., Rösslein, M., & Prina-Mello, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.030 · Cited by 337
Risk Models for Predicting Chemotherapy-Induced Neutropenia
Lyman, G. H., Lyman, C. H., Agboola, O., & Anc Study Group (2005) · The Oncologist · doi:10.1634/theoncologist.10-6-427 · Cited by 336
Stimuli-sensitive nanopreparations for combination cancer therapy
Jhaveri, A., Deshpande, P., & Torchilin, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.002 · Cited by 334
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Su, S., & Kang, P. M. (2020) · Nanomaterials · doi:10.3390/nano10040656 · Cited by 312
Shao, X., Wei, X., Song, X., Hao, L., Cai, X., Zhang, Z., Peng, Q., & Lin, Y. (2015) · Cell Proliferation · doi:10.1111/cpr.12192 · Cited by 310
Advances in self-assembled chitosan nanomaterials for drug delivery
Yang, Y., Wang, S., Wang, Y., Wang, X., Wang, Q., & Chen, M. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.007 · Cited by 301
Polymers and Drug Delivery Systems
Vilar, G., Tulla-Puche, J., & Albericio, F. (2012) · Current Drug Delivery · doi:10.2174/156720112801323053 · Cited by 296
Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges
Tripodo, G., Trapani, A., Torre, M. L., Giammona, G., Trapani, G., & Mandracchia, D. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.032 · Cited by 286
Von Hoff, D. D., Mita, M. M., Ramanathan, R. K., Weiss, G. J., Mita, A. C., LoRusso, P. M., Burris, H. A., Hart, L. L., Low, S. C., Parsons, D. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2548 · Cited by 286
Kokkinopoulou, M., Simon, J., Landfester, K., Mailänder, V., & Lieberwirth, I. (2017) · Nanoscale · doi:10.1039/c7nr02977b · Cited by 283
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
Autio, K. A., Dreicer, R., Anderson, J., Garcia, J. A., Alva, A., Hart, L. L., Milowsky, M. I., Posadas, E. M., Ryan, C. J., Graf, R. P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2168 · Cited by 275
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Fu, Y., Liu, S., Yin, S., Niu, W., Xiong, W., Tan, M., Li, G., & Zhou, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18175 · Cited by 263
Lynn, D. M., Amiji, M. M., & Langer, R. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20010504)40:9<1707::aid-anie17070>3.0.co;2-f · Cited by 256
Protein Polymer-Based Nanoparticles: Fabrication and Medical Applications
DeFrates, K., Markiewicz, T., Gallo, P., Rack, A., Weyhmiller, A., Jarmusik, B., & Hu, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061717 · Cited by 252
Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles
Lima, T., Bernfur, K., Vilanova, M., & Cedervall, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-57943-6 · Cited by 250
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Khang, D., Lee, Y. K., Choi, E.-J., Webster, T. J., & Kim, S.-H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72998 · Cited by 244
Protein bio-corona: critical issue in immune nanotoxicology
Neagu, M., Piperigkou, Z., Karamanou, K., Engin, A. B., Docea, A. O., Constantin, C., Negrei, C., Nikitovic, D., & Tsatsakis, A. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1797-5 · Cited by 236
Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments
Karlsson, J., Vaughan, H. J., & Green, J. J. (2018) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060817-084055 · Cited by 235
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Is prostate-specific membrane antigen a multifunctional protein?
Rajasekaran, A. K., Anilkumar, G., & Christiansen, J. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00506.2004 · Cited by 232
Stirland, D. L., Nichols, J. W., Miura, S., & Bae, Y. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.026 · Cited by 225
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment
Shamay, Y., Elkabets, M., Li, H., Shah, J., Brook, S., Wang, F., Adler, K., Baut, E., Scaltriti, M., Jena, P. V., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7374 · Cited by 220
Gene Therapy in Cancer Treatment: Why Go Nano?
Roma-Rodrigues, C., Rivas-García, L., Baptista, P. V., & Fernandes, A. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030233 · Cited by 220
A review about the development of fucoidan in antitumor activity: Progress and challenges
Wu, L., Sun, J., Su, X., Yu, Q., Yu, Q., & Zhang, P. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.08.005 · Cited by 212
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jászai, J., & Schmidt, M. (2019) · Cells · doi:10.3390/cells8091102 · Cited by 208
Spherical cellulose nanoparticles preparation from waste cotton using a green method
Fattahi Meyabadi, T., Dadashian, F., Mir Mohamad Sadeghi, G., & Ebrahimi Zanjani Asl, H. (2014) · Powder Technology · doi:10.1016/j.powtec.2014.04.039 · Cited by 207
Rationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205
Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Wang, J., Sui, M., & Fan, W. (2010) · Current Drug Metabolism · doi:10.2174/138920010791110827 · Cited by 205
Cai, H., Dai, X., Wang, X., Tan, P., Gu, L., Luo, Q., Zheng, X., Li, Z., Zhu, H., Zhang, H., et al. (2020) · Advanced Science · doi:10.1002/advs.201903243 · Cited by 203
Seaweed Polysaccharide-Based Nanoparticles: Preparation and Applications for Drug Delivery
Venkatesan, J., Anil, S., Kim, S.-K., & Shim, M. (2016) · Polymers · doi:10.3390/polym8020030 · Cited by 201
Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery
Biswas, S., Deshpande, P. P., Navarro, G., Dodwadkar, N. S., & Torchilin, V. P. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.024 · Cited by 197
Arias, S., del Moral, A., Ferrer, M. R., Tallon, R., Quesada, E., & Béjar, V. (2003) · Extremophiles · doi:10.1007/s00792-003-0325-8 · Cited by 195
Gelatin nanoparticles: a potential candidate for medical applications
Yasmin, R., Shah, M., Khan, S. A., & Ali, R. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0009 · Cited by 195
Plants and plant-based polymers as scaffolds for tissue engineering
Iravani, S., & Varma, R. S. (2019) · Green Chemistry · doi:10.1039/c9gc02391g · Cited by 189
Jelvehgari, M., Salatin, S., Barar, J., Barzegar-Jalali, M., Adibkia, K., & Kiafar, F. (2017) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.199041 · Cited by 187
Structural and chemical aspects of HPMA copolymers as drug carriers☆
Ulbrich, K., & Šubr, V. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.007 · Cited by 186
Pagels, R. F., & Prud'homme, R. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.001 · Cited by 183
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
Scheinberg, D. A., Villa, C. H., Escorcia, F. E., & McDevitt, M. R. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.38 · Cited by 180
Behzadi, S., Serpooshan, V., Sakhtianchi, R., Müller, B., Landfester, K., Crespy, D., & Mahmoudi, M. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.09.009 · Cited by 177
Lu, K.-Y., Li, R., Hsu, C.-H., Lin, C.-W., Chou, S.-C., Tsai, M.-L., & Mi, F.-L. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.02.065 · Cited by 176
Potential Applications of Nanocellulose-Containing Materials in the Biomedical Field
Halib, N., Perrone, F., Cemazar, M., Dapas, B., Farra, R., Abrami, M., Chiarappa, G., Forte, G., Zanconati, F., Pozzato, G., et al. (2017) · Materials · doi:10.3390/ma10080977 · Cited by 176
Stimuli‐Responsive Polymeric Nanoparticles for Nanomedicine
Crucho, C. I. C. (2015) · ChemMedChem · doi:10.1002/cmdc.201402290 · Cited by 173
Polymeric Nanoparticles with Neglectable Protein Corona
Alberg, I., Kramer, S., Schinnerer, M., Hu, Q., Seidl, C., Leps, C., Drude, N., Möckel, D., Rijcken, C., Lammers, T., et al. (2020) · Small · doi:10.1002/smll.201907574 · Cited by 173
Tagami, T., Ernsting, M. J., & Li, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.020 · Cited by 164
Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy
Lim, E.-K., Chung, B. H., & Chung, S. J. (2018) · Current Drug Targets · doi:10.2174/1389450117666160602202339 · Cited by 163
Nanoparticle-siRNA: A potential cancer therapy?
Young, S. W. S., Stenzel, M., & Jia-Lin, Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.015 · Cited by 161
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
Baumann, A., Tuerck, D., Prabhu, S., Dickmann, L., & Sims, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.002 · Cited by 161
Alshamsan, A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.12.002 · Cited by 159
Stimulus‐Sensitive Polymeric Nanoparticles and Their Applications as Drug and Gene Carriers
Li, Y., Gao, G., & Lee, D. S. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200313 · Cited by 159
Targeting Hyaluronic Acid Family for Cancer Chemoprevention and Therapy
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-800092-2.00002-2 · Cited by 159
Pasut, G., Paolino, D., Celia, C., Mero, A., Joseph, A. S., Wolfram, J., Cosco, D., Schiavon, O., Shen, H., & Fresta, M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.008 · Cited by 158
Self-citationShreffler, J. W., Pullan, J. E., Dailey, K. M., Mallik, S., & Brooks, A. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236056 · Cited by 158
Mapping of the available standards against the regulatory needs for nanomedicines
Halamoda‐Kenzaoui, B., Holzwarth, U., Roebben, G., Bogni, A., & Bremer‐Hoffmann, S. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1531 · Cited by 157
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 157
Molavi, F., Barzegar-Jalali, M., & Hamishehkar, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.028 · Cited by 154
Minko, T., Batrakova, E. V., Li, S., Li, Y., Pakunlu, R. I., Alakhov, V. Y., & Kabanov, A. V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.019 · Cited by 151
Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
Lee, S. Y., Kang, M. S., Jeong, W. Y., Han, D., & Kim, K. S. (2020) · Cancers · doi:10.3390/cancers12040940 · Cited by 151
Polymer-based drug delivery systems for cancer treatment
Guo, X., Wang, L., Xiao, W., & Zhou, S. (2016) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.28252 · Cited by 148
Potential of Chitosan and its derivatives for controlled drug release applications – A review
Safdar, R., Omar, A. A., Arunagiri, A., Regupathi, I., & Thanabalan, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.020 · Cited by 147
Synthesis of poly(alkyl cyanoacrylate)‐based colloidal nanomedicines
Nicolas, J., & Couvreur, P. (2008) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.15 · Cited by 146
Bennis, S., Chapey, C., Robert, J., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80025-5 · Cited by 142
Saadati, R., Dadashzadeh, S., Abbasian, Z., & Soleimanjahi, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0934-y · Cited by 142
Are Existing Standard Methods Suitable for the Evaluation of Nanomedicines: Some Case Studies
Gioria, S., Caputo, F., Urbán, P., Maguire, C. M., Bremer‐Hoffmann, S., Prina‐Mello, A., Calzolai, L., & Méhn, D. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0338 · Cited by 141
Chinen, A. B., Guan, C. M., Ko, C. H., & Mirkin, C. A. (2017) · Small · doi:10.1002/smll.201603847 · Cited by 140
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier
Tosi, G., Duskey, J. T., & Kreuter, J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1698544 · Cited by 139
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.
Sonnichsen, D. S., Hurwitz, C. A., Pratt, C. B., Shuster, J. J., & Relling, M. V. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.532 · Cited by 137
Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy
Choudhury, H., Gorain, B., Pandey, M., Kumbhar, S. A., Tekade, R. K., Iyer, A. K., & Kesharwani, P. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.018 · Cited by 137
Recent Developments in the Design of Non-Biofouling Coatings for Nanoparticles and Surfaces
Sánchez-Cano, C., & Carril, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031007 · Cited by 136
Rottensteiner-Brandl, U., Sarker, B., Heusinger, D., Dafinova, D., Rath, S. N., Beier, J. P., Kneser, U., Horch, R. E., Detsch, R., Boccaccini, A. R., et al. (2014) · Materials · doi:10.3390/ma7031957 · Cited by 135
Biodegradable polymers for targeted delivery of anti-cancer drugs
Doppalapudi, S., Jain, A., Domb, A. J., & Khan, W. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1156671 · Cited by 130
Design of Polymeric Gene Carriers for Effective Intracellular Delivery
Lai, W., & Wong, W. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.02.006 · Cited by 130
Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug
Chen, K., Cai, H., Zhang, H., Zhu, H., Gu, Z., Gong, Q., & Luo, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.050 · Cited by 129
Maksimenko, O., Malinovskaya, J. A., Шипуло, Е. В., Osipova, N., Razzhivina, V., Arantseva, D., Yarovaya, O. V., Леонидовна, М. У., Khalansky, A. S., Федосеева, В. В., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118733 · Cited by 127
Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications
Gulati, N. M., Stewart, P. L., & Steinmetz, N. F. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00292 · Cited by 126
Complicity of degradable polymers in health-care applications
Anju, S. M., Prajitha, N., Sukanya, V. S., & Mohanan, P. V. (2020) · Materials Today Chemistry · doi:10.1016/j.mtchem.2019.100236 · Cited by 124
Chen, N., Li, Y., Ye, Y., Palmisano, M., Chopra, R., & Zhou, S. Y. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.304 · Cited by 123
To what extent do polymeric stabilizers affect nanoparticles characteristics?
Madkour, M., Bumajdad, A., & Al-Sagheer, F. A. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.05.004 · Cited by 122
Peng, Y., Nie, J., Cheng, W., Liu, G., Zhu, D., Zhang, L., Liang, C., Mei, L., Huang, L., & Zeng, X. (2018) · Biomaterials Science · doi:10.1039/c7bm01206c · Cited by 120
Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system
Gagliardi, A., Paolino, D., Iannone, M., Palma, E., Fresta, M., & Cosco, D. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s156930 · Cited by 120
Self-citationRecent advances of using polyhydroxyalkanoate‐based nanovehicles as therapeutic delivery carriers
Li, Z., & Loh, X. J. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1429 · Cited by 118
Joerger, M., Huitema, A. D. R., Richel, D. J., Dittrich, C., Pavlidis, N., Briasoulis, E. C., Vermorken, J. B., Strocchi, E., Martoni, A. A., Sorio, R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0064 · Cited by 114
αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future
Demircioglu, F., & Hodivala‐Dilke, K. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.07.008 · Cited by 112
Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy
Edelman, R., Assaraf, Y. G., Levitzky, I., Shahar, T., & Livney, Y. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15363 · Cited by 111
Chen, H., Qin, J., & Hu, Y. (2019) · Molecules · doi:10.3390/molecules24030617 · Cited by 111
Polymer‐based stimuli‐responsive nanosystems for biomedical applications
Joglekar, M., & Trewyn, B. G. (2013) · Biotechnology Journal · doi:10.1002/biot.201300073 · Cited by 109
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Medicines · doi:10.3390/medicines6010007 · Cited by 108
Self-citationChoudhury, H., Gorain, B., Pandey, M., Khurana, R. K., & Kesharwani, P. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.042 · Cited by 107
Hu, Q., Rijcken, C. J. F., Bansal, R., Hennink, W. E., Storm, G., & Prakash, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.085 · Cited by 106
Multifunctional drug delivery system for targeting tumor and its acidic microenvironment
Shen, M., Huang, Y., Han, L., Qin, J., Fang, X., Wang, J., & Yang, V. C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.013 · Cited by 103
You, Y., & Oupický, D. (2006) · Biomacromolecules · doi:10.1021/bm060635b · Cited by 101
Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy
Domínguez-Ríos, R., Sánchez-Ramírez, D. R., Ruiz-Saray, K., Oceguera-Basurto, P. E., Almada, M., Juárez, J., Zepeda‐Moreno, A., Toro‐Arreola, A. D., Topete, A., & Daneri‐Navarro, A. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.03.011 · Cited by 101
Raveendran, S., Poulose, A. C., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.07.079 · Cited by 100
Guo, W., Quan, P., Fang, L., Cun, D., & Yang, M. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2015.06.001 · Cited by 99
Measurement of Fraction Unbound Paclitaxel in Human Plasma
Brouwer, E., Verweij, J., De Bruijn, P., Loos, W. J., Pillay, M., Buijs, D., & Sparreboom, A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0026-895x(24)12040-8 · Cited by 98
The use of zein in the controlled release of poorly water-soluble drugs
Tran, P. H. L., Duan, W., Lee, B., & Tran, T. T. D. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.018 · Cited by 97
Weber, C., Simon, J., Mailänder, V., Morsbach, S., & Landfester, K. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.057 · Cited by 94
Mosqueira, V. C. F., Legrand, P., Gref, R., Heurtault, B., Appel, M., & BARRATT, G. M. (1999) · Journal of drug targeting · doi:10.3109/10611869909085493 · Cited by 92
Zheng, X., Pan, D., Chen, M., Dai, X., Cai, H., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2019) · Advanced Materials · doi:10.1002/adma.201901586 · Cited by 92
Pan, D., Zheng, X., Zhang, Q., Li, Z., Duan, Z., Zheng, W. X., Gong, M., Zhu, H., Zhang, H., Gong, Q., et al. (2020) · Advanced Materials · doi:10.1002/adma.201907490 · Cited by 92
Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy
Sarcan, E. T., Silindir‐Gunay, M., & Özer, A. Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.019 · Cited by 91
Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus
Chiesa, E., Dorati, R., Conti, B., Modena, T., Cova, E., Meloni, F., & Genta, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082310 · Cited by 90
Rho, J. G., Han, H. S., Han, J. H., Lee, H., Nguyen, V. Q., Lee, W., Kwon, S., Heo, S., Yoon, J., Shin, H. H., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.006 · Cited by 89
Magadala, P., & Amiji, M. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9065-0 · Cited by 87
Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
Scripture, C. D., Figg, W. D., & Sparreboom, A. (2005) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.1.2.107.62910 · Cited by 86
Polysaccharide-based Nanoparticles for Gene Delivery
Huh, M. S., Lee, E. J., Koo, H., Yhee, J. Y., Oh, K. S., Son, S., Lee, S., Kim, S. H., Kwon, I. C., & Kim, K. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0114-y · Cited by 84
Characterization and refinement of zein-based gels
Gagliardi, A., Froiio, F., Salvatici, M. C., et al. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2019.105555 · Cited by 84
Self-citation
Cited by
Biopolymer: A Sustainable Material for Food and Medical Applications
Baranwal, J., Barse, B., Fais, A., Delogu, G. L., & Kumar, A. (2022) · Polymers · doi:10.3390/polym14050983 · Cited by 727
Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 329
Recent advances in biodegradable polymers – Properties, applications and future prospects
Mukherjee, C., Varghese, D., Krishna, J. S., Boominathan, T., Rakeshkumar, R., Dineshkumar, S., Brahmananda Rao, C. V. S., & Sivaramakrishna, A. (2023) · European Polymer Journal · doi:10.1016/j.eurpolymj.2023.112068 · Cited by 321
Yang, J., Dai, D., Zhang, X., Teng, L., Ma, L., & Yang, Y.-W. (2023) · Theranostics · doi:10.7150/thno.80687 · Cited by 277
Yang, J., Luly, K. M., & Green, J. J. (2023) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1853 · Cited by 40
Metadata
- Authors
- Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-03
- Volume
- 12
- Pages
- 601626-601626
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3129058300
- Cited by
- 571
- References
- 266
- FWCI
- 21.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.